Avient Corporation

Good morning, ladies and gentlemen, and welcome to AVN Corporation's webcast to discuss the company's first quarter 2022 results and agreement to acquire DSM Protective Materials. My name is Gigi, and I'll be your operator for today. At this time, all participants are in a listen-only mode. We will have a question and answer session following the company's prepared remarks. As a reminder, this conference is being recorded for replay purposes. I would now like to turn the call over to Joe DiSalvo, Vice President, Treasurer and Investor Relations. Please proceed.

Thank you, Gigi. Good morning to everyone joining us on the call today. Before beginning, we'd like to remind you that statements made during this webcast may be considered forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements will give current expectations or forecasts of future events and are not guarantees of future performance. They're based on management's expectation and involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statement. Please refer to the investor presentation for this webcast for a number of factors that could cause actual results to differ. During the discussion today, the company will use both GAAP and non-GAAP financial measures. Please refer to the presentation posted on the Avian website where the company describes non-GAAP measures, and provides a reconciliation for historical non-GAAP financial measures to their most directly comparable GAAP measures. Joining me today is our Chairman, President, and Chief Executive Officer, Bob Patterson, and Senior Vice President and Chief Financial Officer, Jamie Beggs. Now, I will turn the call over to Bob.

Well, thanks, Joe, and good morning, everyone. We have record results to share today and exciting news about our agreement to acquire DSM protective materials. Our performance continues to be underpinned by the investments we made to transform our portfolio to one that is more specialized and concentrated in less cyclical high growth end markets. This acquisition will continue that journey we started well over a decade ago. I look forward to sharing more with you about DSM protective materials after Jamie covers our first quarter results.

Thanks, Bob. Despite challenging macroeconomic and geopolitical conditions, We grew sales, adjusted operating income, and adjusted EPS by 11% year-over-year. Excluding negative foreign exchange rates, adjusted EPS increased 16%. From a segment perspective, specialty engineered materials led the way, expanding operating income by 18%. While SEMs did see some softness in certain outdoor high-performance applications, they They delivered a record quarter with significant growth and sustainable solutions, as well as other differentiated composite applications. Our color segment was most significantly impacted by weaker foreign exchange rates, as well as the unforeseen and tragic war in the Ukraine. The war weighs heavy on our hearts and our thoughts are with the people whose lives have been disrupted forever by the invasion. Avian does not manufacture in Russia or the Ukraine, but historically has imported colorants into the region approximately $6 million in sales and $3 million in operating income per quarter. Sales to the region has effectively ceased, resulting in about a million-dollar negative impact on Q1. Clearly, this is not a significant exposure for us, but is impacting us presently. In distribution, pricing more than offset historical logistical – I'm sorry – higher logistical costs and lower volumes into transportation. However, we did see some margin compression related to a sequential decline in polyethylene and polypropylene to start the quarter that is starting to reverse itself in Q2. The next slide shows the bridge illustrating the key growth drivers of sustainable solutions, healthcare, and composites. Phenomenal results, especially considering the impact of the Omicron variant, which rippled through the Americas and Europe early in the quarter, and now COVID is more acutely impacting China, resulting in government-mandated lockdowns. Our Q1 EBITDA bridge highlights the great work by the team to navigate through all of these challenges and ensure we stay ahead of inflation. Price increases for all three segments more than covered raw material inflation and also covered the other supply chain disruption costs incurred to deliver value for our customers. You can also see on this slide the currency impact, primarily driven by the euro, which is more significant than we initially anticipated. The last bridge simply captures the previously described performance in adjusted EPS terms and also shows that a higher tax rate this year negatively impacted EPS by about two cents versus the prior year. Our outlook statements today will be brief. As we look forward to the rest of the year, we see customer-driven innovation expanding our sales in sustainable solutions, healthcare applications, advanced composites, and other key end markets. However, we can't ignore that China has effectively shut down three of our plants in Shanghai and many of our customers' operations, which has impacted Asia demand as well as further complicated supply chain dynamics. For the full year, we assume that the aforementioned import sales into Russia and the Ukraine do not resume, but that we are able to offset this as well as weaker foreign exchange rates with stronger full-year growth projections in the Americas. As such, we are maintaining our full-year adjusted EPS guidance of $3.50 per share before any adjustment for the acquisition, and we are introducing guidance of 92 cents per share for the second quarter. We will be happy to take questions about our financial performance and projections at the end of the call, but now we want to focus our attention on the announced agreement to acquire DSM protective materials. And with that, I will hand the call back over to Bob.

Well, thanks, Jamie. We're very excited to announce our agreement to acquire DSM protective materials as the next step in our specialty transformation. The foundation of the business is the renowned technology and globally admired brand of Dyneema, the world's strongest fiber. And you will hear us refer to the business interchangeably with this brand name today. The ultra lightweight specialty fiber is 15 times stronger than steel, while still being light enough to float on water. It is used in a number of demanding applications that we will cover in more detail shortly. From a headline perspective, The purchase price represents an 11.4 times multiple of projected Dyneema sales of $415 million in EBITDA of $130 million in 2022. The business includes six production facilities, four R&D centers, and 1,000 employees located around the world. With EBITDA margins north of 30%, it is truly specialty. Dyneema will be reported within our engineer materials segment, significantly expanding our composite and fiber portfolio, which we have long stated our intentions of doing. The acquisition is immediately accretive to adjusted EPS, adding 35 cents on a pro forma annualized basis for 2022, excluding intangible amortization. From a strategic perspective, Dyneema is a perfect fit with complementary strengths in each of our four pillars and includes an impressive leadership team. Theirs is a culture passionate about innovation and solving customer challenges just like ours. Dyneema serves three key industries today, personal protection, marine and sustainable infrastructure, and consumer. Application examples include fiber materials for personal protection, such as vehicle and body armor with the primary end users being the military and law enforcement. Marine and sustainable infrastructure includes high-strength mooring lines, ropes, and slings for heavy lift applications, offshore wind farms, and sustainable aquaculture. Consumer applications include high-performance ropes and lines for sailing, yachting, and ultra-low-weight, high-strength outdoor applications for archery, backpacking, and fishing and other outdoor activities. Another well-known application is cut-resistant gloves, which are made possible by this incredible technology, reducing risk, and improving safety in countless work and home environments. Ultimately, each of these applications is backed by best-in-class technology, which is well protected with over 1,300 patents, more than doubling the total patent portfolio for Avian as a whole. The properties of Dyneema are unmatched when it comes to the ratio of strength versus weight. Combined with its many other unique characteristics, it is designed for end uses where failure is not an option. The chart on this slide shows the relative performance of Dyneema versus other competitive materials as it relates to personal protection applications. Dyneema is presented in dark blue squares on the graph. The large oval in the upper right illustrates a range of performance inclusive of recent innovations in a lab environment representing the next generation of technology. Like Avian, Vynema is focused on formulations and material science. By combining polymer and fiber, it customizes various shapes and forms to be used by fabricators to produce high performance applications. We illustrate this on the next slide where you can see sheets being converted to ballistic panels, and fiber being spun to create ropes for sustainable marine applications. This is quite similar to what we do at our polystrand and fiberline facilities today. Fiber, sheets, and tapes are customized for each fabricator, who then produces interim products for key OEMs, who specify the performance required for each application. And as with Avian, Dyneema works across the entire value chain to formulate solutions to solve customers' most challenging problems. And demand trends for these solutions continue to grow. Recent events have created momentum around increased military spending, not to mention the growth expected from investments in next-generation technology. Solutions around sustainable infrastructure, such as floating offshore wind farms and aquaculture, also continue to advance. In fact, offshore wind installations are expected to quadruple over the next five years. Lastly, in a space we know very well, outdoor high-performance applications are expected to grow double digits, which is aligned with the growth expectations we have for Avian's composite portfolio. From a sustainability standpoint, Dyneema aligns very well with how we help our customers achieve their sustainability goals. This includes reducing weight and energy use, as well as protecting human health and safety. Avian's sustainable solutions portfolio has grown at a 12% organic CAGR since 2016, with revenues reaching $915 million. last year. We have committed that our future investments in innovation will concentrate on enabling sustainability for our customers and the world. Dyneema puts us in an even stronger position to do just that. In 2012, we completed our first acquisition in the composite space. Since then, we have strategically added complementary technologies through a series of bolt-on acquisitions to create a unique portfolio of solutions. And early returns have been impressive, but as you can see, Dyneema will bring us substantially more size and scale, as well as increased profitability. We are very excited about this newest addition and the step change in specialization for the company overall. I view this as an important next step and a total portfolio transformation that began over 15 years ago. In this regard, we are considering a sale of our distribution segment. As you know, the distribution business was part of the original formation of Poly1 in 2000. Since that time, the business has grown into a leader in North American plastic distribution with a world-class supplier line card. It has built an unmatched position in the healthcare space and developed leading technology in digitally interfacing with customers. And lastly, it has been a cash flow generating machine, cash that we have put to work to fund our specialty growth. With our announced acquisition of Dyneema, we are at an inflection point as we can leverage future cash flows of the business, or accelerate that with a potential sale, which we are going to explore. A sale process could ultimately unlock even more value for shareholders as Avian would then be viewed as a pure play specialty company. I will now hand the call over to Jamie to review the transaction financials and related modeling, and then I will make some closing remarks before we take your questions.

Thanks, Bob. I share Bob's enthusiasm for this great business and the transformational element it brings to our journey. As you read in our news release, the net purchase price for this business represents an 11.4 times multiple unexpected 2022 EBITDA. We have committed financing in place with Morgan Stanley and JP Morgan. Permanent financing will constitute a combination of cash on hand, new unsecured notes, and new senior secured term loans. Proceeds from the potential sale of our distribution business could be used to pay down our 2023 senior notes and or other prepayable debt. As is customary, the deal is subject to regulatory approvals and closing conditions, which we expect to be completed in the second half of 2022. We laid out the capital structure on slide 24, which includes the new debt expected to fund the acquisition. The resulting 2.9 times lever is pro forma for both the potential divestiture of our distribution business and the acquisition of Dyneema. This structure is aligned with our proven track record of disciplined capital allocation. Our existing dividend policy will be maintained and expected to grow annually with underlying earnings. As you may recall with the Clariant color acquisition, we also maintained a disciplined capital allocation policy which allowed us to be lever ahead of schedule to create the capacity we have today to invest for the future. We plan to follow the same playbook with Dyneema by being modestly levered and committed to reducing leverage over time as we grow and integrate the business. By 2024, we expect net leverage to drop to 2.2 times. This positions us very well to continue to invest in the business and drive future growth. Our pro forma modeling illustrates first the impact of acquiring Dyneema on a pro forma basis for 2022, and second, a potential sale of distribution. We are using our current assumptions for 2022 performance, but introduced an adjusted EPS metric, excluding the impact of amortization associated with intangible assets. The headline impacts are significant with respect to the expansion of EBITDA margins from 12% to 18%, while maintaining a very modest level of leverage at 2.9 times net debt to adjusted EBITDA. With that, I'll turn the call back over to Bob.

Thanks, Jamie. I've been with the company for 14 years now, and it has been exciting to see the transformation of Avian and become a truly specialty enterprise. We have done this with a combination of investment in commercial resources, to accelerate innovation to drive organic growth, as well as select acquisitions to build out our color and engineer material segments. From an acquisition perspective, we have a great track record with bolt-ons. I love this slide as it highlights the power of investment to drive specialty growth, better serve our customers, and expand margins. And we have done this on a large scale as well. The Clarion acquisition has arguably been our most successful in terms of size, scale, and our ability to integrate two world leaders seamlessly. Since we announced the acquisition, adjusted EBITDA has increased over 50%, while expanding margins and delevering faster than originally modeled. As we look ahead to Dyneema, I want to emphasize that this is not a cost-cutting play. This is a capabilities play. We plan to invest in the business to help drive growth, as we have with our previous acquisitions, and we also have the opportunity to create a pure play specialty company. This slide captures that very well and illustrates the mixed impact of the pro forma modeling Jamie covered a few moments ago. But to me, it represents something more as it highlights the multi-year transformational journey we have been on to create a truly special and unique portfolio. I'm incredibly proud of what we have accomplished so far, but more excited about what the future holds. Before we take your questions, many of you have seen our peer comparison slides in the past. I'm replaying one of them here to illustrate that on a pro forma basis, our EBITDA margins will be higher than the comparable specialty formulators on this page. This, in combination with the growth characteristics of sustainable solutions and composites, should provide a compelling case for expanding valuation. But none of this would be possible without our associates and the great place to work culture we have created. In this regard, I look forward to welcoming the 1,000 Dyneema employees, who I am sure will help us become an even better place to work and higher performing organization. In summary, we are at the next stage of our transformational journey, where we feel our momentum is stronger than ever. We are excited about the acquisition of DSM protective materials and the management team coming with it. Dyneema adds one of the world's most remarkable technologies to Avian's already diverse specialty portfolio. It's a technology we plan to invest in, to grow, and to add value for all of our stakeholders well into the future. Thank you all for joining today for our exciting announcements, and with that, we are happy to take any questions you may have.

As a reminder, to ask a question, you will need to press star 1 on your telephone. To withdraw your question, press the pound key. Please stand by while we compile the Q&A roster. Our first question comes from the line of PJ Juvicar from Citi. Your line is now open.

Great. Thank you. Just a couple of questions on Dyneema. Can you remind us what the trailing EBITDA multiple on that business is or what you're buying? And, you know, this significantly increases your exposure to Europe at a time when Europe is facing a multitude of challenges. What's your thinking there? And then I have one more question after that.

Yeah, it's 12.4 times trailing 12 months. We did about $120 million in 2021. And then with respect to Europe, I mean, it's actually a pretty balanced organization in terms of their exposure worldwide with about 175 million of the 415 in Europe. So to me, I view this as a global business and, you know, one where obviously the technology helps us expand our composites portfolio. So, I mean, clearly these are uncertain times globally. But I feel confident in the numbers that we've put together and our ability to finance the deal.

Great. And I have a question on your base business. How much was the raw material basket up in one queue? And it seems like raw materials have continued to go up in two queues with natural gas now over $7 and polyethylene and PVC all going up as well. Can you just talk to us about what pricing power you have in the sort of remaining two businesses, CAI and engineered materials? Thank you.

Yeah, I mean, in the first quarter, you can get – actually, if you look at the specific line items by segment, it will show you how much the impact of raw material cost was by each. I would refer to that. From a pricing standpoint, we've been able to more than offset that in each of the segments. And I expect that we're going to continue to be able to do that through the balance of the year. With the last element of your question there, obviously, you know, with underlying inputs and hydrocarbon costs going up, that inflation may happen at an even faster pace. But we're prepared to handle that really just as we have since the COVID pandemic began. So we've stayed out in front of it. all well during this time, and we will continue to do so through the balance of this year. Thanks, Bob. Certainly. Thank you.

Thank you. Our next question comes from the line of Mike Sison from Wells Fargo. Your line is now open.

Hey, good morning. Really nice deal there. Congrats. In terms of Dyneema, can you maybe talk about what the growth rate for the business has been over the last couple of years and going forward, what you think the business could contribute in terms of growth and any sales synergies, do you think, with your current composites business that you can generate?

Yeah, I mean, so on the first part of that question, the underlying EBITDA has grown at about 10%, which is really quite in line with our own expectations for our composites portfolio and what we've seen in the last few years. So I think there's good alignment with that, Mike, if you're to go back in time and look at the details. Yeah, from a sales standpoint, I think first and foremost, we're really excited about the technology and innovation. And I do think there's an opportunity for some overlap with our fiber line business, as well as our polystram business to help bring those technologies together. I view really the Dyneema business is bringing a premier technology to the portfolio and expect it could help both those two areas of the business from a sales standpoint.

Right. Great. And then in terms of distribution, what's the tax effect on – I would imagine the basis is pretty low. And then can you maybe walk us through the – the process for potentially selling it, and what do you think the appetite for that business will be?

First of all, this is a great business, as you know. It's one that we have talked positively about for years. I do think that there will be a great deal of interest in the business. There always has been since I've been with the company. I expect that to be the case. I think the federal tax rate we're using is 25, right? Sorry. And then you've got to add state and local, et cetera, on top of that. So as we've said, probably anytime anyone has asked us this question in the past, I mean, there is a pretty significant tax impact on a direct sale because ultimately the basis is low and that it's really just working capital in the business.

Great. Thank you.

Thank you. Our next question comes from the line of Frank Misht from Fermion Research. Your line is now open.

Good morning, and congrats on the transaction. In terms of distribution, as I'm calculating the pro forma net leverage, it doesn't seem that bad, to be honest with you, and that has been a pretty good business, a pretty good return on capital business for sure. I understand that selling it will get you to that 100% specialty level, that you're seeking, but it becomes a very small part of the overall company. Can you talk a little bit more about the decision that you want to monetize that business?

Yeah, maybe I'll take the middle comment there first and say it is obviously a very small part of the company, and with the Dyneema acquisition becomes even smaller. It is a very high return on invested capital. As you know, we have you know long sort of stress that as an important reason for owning it and so As it is smaller. I think that means that there is less of a need to sell Frank But certainly view this as an inflection point to consider doing so the one thing that we really have in mind is that obviously, you know a sale process would lower that leverage below three times and And that actually kind of helps to set us up for more capacity for specialty growth in the future. So we really, as with any decision like this, just need to weigh what we think the future prospects are of the business with respect to what that looks like on a present value basis in a sale process. So that process is one that we're going to explore. We'll certainly keep everybody updated as we go forward and learn more.

Got you. Okay, so no, nothing, no reason for panic selling here. If you get a good price, then you'll you'll execute on it. And it's just a question on slide 20. I pulled out my abacus. And as I looked at the delta between 22 and 21, it looks like you're calling for your base composites business to grow by 1 million and EBITDA in 22. Can you talk about, you know, what your expectations are for the composites growth in in 2022?

Yeah, the biggest reason is that there's certain outdoor applications that are going to be down for the year. And that's something that we actually did have in our, I think our initial guidance is when we went out. It's all being offset effectively by, you know, new business gains and other applications. But looking to 350 overall, we always had an expectation that some of the outdoor business would be down this year. And that's still the case. So that's really the reason why it's showing up. I think, Frank, on one of the bridges in the quarter, you'll actually see the outdoor high-performance piece split out versus the other composite businesses. And we can give you some better numbers on that for the full year, too.

Thank you so much.

Yep.

Thank you. Our next question comes from the line of Angel Castillo from Morgan Stanley. Your line is now open.

Hi, good morning, and congratulations on the deal. Bob, Jimmy, I was hoping you could give us a little bit more color on the Dyneema business as you think about the visibility that that business has with maybe a lot of exposure to government. Just give us more color as to maybe what the contract structures are, what the visibility is, and as you think about that $130 million of EBITDA, how certain is that versus maybe how much of a kind of, I guess, range there could be in ultimate outcome there?

Yeah, I mean, first of all, I'd refer you back to, you know, one of the slides in the deck that just shows, you know, the Dyneema and the value chain. Because I just want to be clear, look, that Dyneema isn't selling directly into the military or law enforcement themselves. I mean, in fact, they've got a sales model that's very similar to aviance in that, you know, really what they're manufacturing is a fiber or a unidirectional sheet. which is then ultimately fabricated by a customer sold to an OEM who then sells to those end applications. So there's a little bit of a chain dynamic there, Angel, with respect to the connection to some of those end-use applications. I think that you can look at those, though, and say that there is some additional predictability to the business just based on some longer-term contracts that exist with these OEMs and those end-users. And that, I think, does help to bring some stability to the business. But overall, at this point, we've got a growth rate expectation for the business aligned with really our composites portfolio overall.

That's very helpful. Thank you. And then I was hoping we could talk about kind of the 2Q guide and maybe the bridge to that. You've talked a little bit about maybe the raw materials and, you know, some aspects that we're seeing a little bit more inflation and perhaps at a faster clip. But, you know, as you have done over the last few quarters, continuing to price ahead of that, I'm just curious, you know, as we think about what's embedded in that 92 cents for the second quarter, you know, I guess any particular areas outside of outdoor performance products or, you know, maybe automotive or transportation that's weak and within, you know, raw materials as well? Or is it just purely a timing thing and we'll get that back with price and 3Q and 4Q?

Yeah, I mean, the Q2 guidance really isn't a matter of inflation. As you can see in our first quarter, we've more than covered that with pricing. That's been the case five quarters in a row now. you know, if you go back to when inflation really started to pick up at the beginning of 2021. So that's really not what Q2 is about. What Q2 guidance reflects is that four of our facilities in China are currently closed because of COVID lockdowns. That's the single biggest reason for sort of an updated view on guidance there. And then secondly, You know, although the import business into Russia and Ukraine is small, we effectively assume that goes away. With respect to Asia, I am viewing that as a short-term phenomenon because the orders are there and the expectation is that when our plants come back online that we can ultimately catch up. I'm just not sure we can get all that done in the second quarter. as the timing of reopening is still a question mark in China.

Very helpful. Thank you.

Thank you. Our next question comes from the line of Mike Harrison from Seaport Research. Your line is now open.

Hi. Good morning, and congratulations on a good start to the year and on the deal. I wanted to ask about slide 19 here, where you, I think, do a good job kind of laying out that you have built this composites portfolio out of a set of different acquisitions, but just trying to get a little bit better sense of how Dyneema fits into your existing offering. I think you mentioned that there are some similarities or overlaps with the fiber line and polystrand businesses. But should we think of this as complementary? Should we think of it as filling some technology gaps? And I guess as we go forward here, you know, is this really an enabling acquisition that's going to even fuel some additional bolt-on activity in composites?

Yeah, so while you're looking at page 19, I mean, there's a visual depiction there of six different types of composite fiber materials that we do today. The three that best illustrate what Dyneema does is the tapes, the panels, and the fibers. So it's really an exact fit into those three buckets, Mike. I hope that helps visually put that into context in terms of what Dyneema does. And look, we do view this as an opportunity to really obviously significantly expand the composites portfolio, and I would still view that as an attractive area for further investment with respect to additional acquisitions in the future.

All right. And then in terms of the sustainability aspect, it looks like Dyneema is working on some ultra-strong bio-based materials that also some materials that will fit into the circular economy on the composite side. Can you talk maybe in a little bit more detail about how this acquisition expands the sustainable solutions angle?

Yeah. First of all, I would just say that in my time spent with the management team, they have an absolute passion for sustainability and recognize the importance of supporting a circular economy. Using bio-based materials is probably one of the leading innovation ideas that exist for theirs, for some of the ropes, lines, and fibers, et cetera, particularly those that are used in some of these marine and aquaculture applications. But as you know, Mike, look, bio-based material is in short supply, so kind of like the amount of recycled content that exists today. What I do think is that supply level increases, that there's a real opportunity to help drive growth and really support the sustainable solutions. Look, in addition to simply being a lightweight material. So I think there's a lot of different and positive angles here with respect to sustainability that Dyneema is all over.

All right. If I can just sneak one in quickly. It looks like the other supply chain cost line that you use in your bridge there came down pretty dramatically in Q1. You're calling out $4 million in Q1 versus, I think, $15 million in Q4. Have those costs continued to trend more favorably as you think about supply chain challenges? Or are things worsened as you look at March and April between Ukraine and the COVID situation in China?

I mean, one of the things I'd have to go back and look at Q4 is whether or not we had supply chain kind of commingled with wage inflation. I don't remember. We might have. We've now split the two out, so that might be part of the explanation, but I'll have to go back and see.

Some of the caps are getting better now because the issue started last year at Q1, so the caps are now.

Yeah, thank you. So, I mean, part of that too, Mike, is just that you're kind of lapping some of the bad guys that really came into effect in 21. And so I do view that as getting better.

All right. Thanks very much.

Thank you. Our next question comes from the line of Christian Owen from Oppenheimer. Your line is now open.

Hi, thank you for taking the questions and congratulations on the nice quarter. I wanted to ask about the incremental 1,000-person headcount that you're bringing into the portfolio along with some substantial IP. Talk to us about how important the talent acquisition was to bringing it to the table. And, you know, Bob, I know you said this wasn't a deal based on cost synergies, but given the strength of that portfolio, can you speak to any of the potential for R&D synergies?

Yep. First of all, I'm just very impressed with the management team and clearly what they, along with DSM, have built here is very impressive from a technology standpoint. Culturally, I also think they kind of share our view with respect to customer service and the sort of obsession, if you will, with solving customers' challenges. It is a very unique material. It's a premier material. And they think about that in those terms. And so I'm, again, I think they share our perspective on specialization. And I also just think they've got a passion for this business. You know, this Dyneema brand is incredibly powerful. It's well known. And I think there's a lot of, a lot to that brand and how well the team, you know, sort of, you know, coexist together with that as a guiding force or, or principle behind what they do and why they do it. So I love the team. I'm looking forward to them joining the company. That is a big part of our evaluation of any deal is really, is this going to be a cultural fit or not? I think that if it's not a good cultural fit, a lot of times it's not the right deal. That's just too hard to overcome. So anyway, I think we have a lot in common. I think we'll hit the ground running when we start. And I am excited about the latter part of your question with respect to innovation and technology. I have a sense that when you kind of consider the size and scale of what Dyneema does today versus Polystrand, you know, a small composite business of ours, that we probably have a lot to learn from them. So that's my expectation, but I think it'll be a two-way once we can start to work together on that.

Appreciate that color. And then if I could just ask on the quarter a little bit of additional end market commentary, specifically on the consumer side. Certainly the inflationary environment is causing concerns about consumer spending. Just wondering if you can talk a little bit about what you're seeing on the ground in the various consumer end markets that you touch, sort of outside of that outdoor performance bucket that you've already called out. Thank you.

Yeah, I mean, so one, obviously there's, look, with respect to the outdoor industry, it really is a pretty narrow set of applications that we're seeing down this year. There's still strength in things like off-road vehicles, for example, which, you know, I think the OEMs are still struggling to keep up with demand. Dealerships are largely empty still, and there's a waiting list for a number of things. So, Really, it's kind of a narrow focus on the outdoor side where we're seeing that down this year. In general, consumer demand has been good. If I look at consumer staples, I actually think that's been up even more. So in general, I still view the consumer market as positive. But I have to highlight that a lot of that's really driven in the Americas where we're seeing most of that growth. So there are some regional differences. Certainly with what we saw in Asia to start the year, it's hard to kind of bifurcate. The orders are there, but it's kind of hard to bifurcate the impact on the quarter with respect to Omicron, the lockdowns and so on, which is impacting all the markets there. So in general, I'd say consumer's doing pretty good, but heavily driven by what we're seeing in the Americas.

Thank you. Our next question comes from the line of Lawrence Alexander from Jefferies. Your line is now open.

Good morning. It's Dan Rizzo on for Lawrence. How are you?

Hi, Dan.

Hey. So have you talked at all about the stranded costs that would potentially be associated with the divestiture of the distribution business?

That's factored into our modeling. It's pretty small. It's probably about $8 million or so.

Okay, and then with the acquisition of Dyneema, does this make you less agnostic on materials used in formulations? Are you going to be shifting to maybe create vertical integration in thermoplastics? How should we think about that?

Well, it's interesting because Dyneema does have some vertical integration with respect to certain areas of supply. I'm not sure that necessarily changes my view on that for the company as a whole, because I really do view our core competence and expertise as formulation. So anyway, I think it's a strength for Dyneema. It's an asset. We like it. I'm not sure that necessarily changes anything with respect to the company as a whole, other than possibly just looking at different ideas for the composites platform where that could possibly change once Dyneema is part of us.

All right, thank you very much.

Thank you. Our next question comes from the line of Vincent Anderson from Stiefel. Your line is now open.

Yeah, thank you, and good morning. So going back to Dan's question a bit, you know, what is Dyneema's current capacity balance between their high molecular weight PE resin and the derivatives that they ultimately make from it? And are those facilities configured today to be able to expand resin capacity fairly easily to facilitate future growth?

Yeah, so they have capacity expansion plans to really see them through 2024. It's one of the items I'd say we diligence perhaps most significantly to really understand that. ultra-high molecular weight polyethylene that's coming into the business is really not a bottleneck at all. It's more in the manufacturing side with respect to unidirectional materials and fiber. But there are investments being made right now. And that's all inside the existing walls of their footprint. So all very doable things. When I look at growth outside of 24, I think there's incremental capex to add a line, and that's probably something that we would start to plan on doing once Dyneema is part of us.

Okay. All right. Very helpful. And you've addressed this to some extent already, but maybe to just ask more directly, down the road, does Dyneema as a material have an opportunity to be used in structural applications or tapes? And in a similar vein, You said your thinking hasn't changed on your level of integration into thermoplastics, but given kind of the specificity of ultra-high molecular weight polyethylene, are you viewing that material more broadly as an opportunity to expand on in your portfolio?

Yeah. I mean, so I think there's an opportunity inside or to go into more structural elements. That's actually... aligned with what we do today, for example, in our glass form facility, as well as a little bit in our polystrand facility. So we have some familiarity with that end market. I'd say for now, the focus for Dyneema is really supporting the growth in the key end markets that they're in today. I think that we can help them grow on the consumer side. That's an area that we know very well, particularly in the outdoor high-performance applications. And then, can you repeat the last part of your question? Because I don't want to mess that up.

Yeah, sorry. So, just given that ultra-high molecular weight polyethylene is already a fairly highly specified material on its own, even if it's still a base resin, do you view that more broadly as something to grow on from a commercial perspective? Oh, I see.

Well, at this point, I mean, we really view that as an input ultimately to the Dyneema business. There has been some of that's been sold out into the marketplace, but for us, and maybe to put it in the context of, you know, the capacity question that was asked earlier, I see that more going towards Dyneema to service the capacity for the growth that we see in those end markets versus going out and selling that separately.

Okay, excellent. Thank you.

Thank you. Our next question comes from the line of Jadiv Pandya from On Field Research. Your line is now open.

Thank you. I think the first question really is around the sales growth, the top line growth of this business. It has sort of remained around about 300 million euros in the last, say, four or five years, despite sort of the ebbs and flows of the market. So, Do you think, you know, when you did the due diligence, you know, what is in your view the fundamental growth of this business? And, you know, like the Clarion acquisition, which was sort of a business within a broader group, which was to a degree less of a focus, do you think Dyneema also is a case where, you know, DSM is a nutrition-based company and therefore maybe from a growth point of view it did not get enough attention and you will be able to unlock the growth potential for this business. That's my first question. The second question is just really around the process itself, really. I mean, have you been looking in this area because again, obviously this has been an asset on not really truly on the market, but it has been rumored that it will come on the market for a few years now. So was this a business which like Clarion again, you know, you always, you know, were focused on acquiring if it ever came to the market or not. And then just finally, could you give us some end market comments around what are you seeing currently in important end markets like autos, electronics, you know, construction, et cetera, based on your sort of recent last month or, you know, current month sales? Thanks a lot.

So to begin with, I would say that, yes, this is an acquisition that we have been thinking about for some time. We've had dialogue with DSM over the years, and there are similarities to it with respect to Clarion in that they, I do believe, had the idea that it would ultimately be a sale candidate and it was a matter of timing for them. So we were always assured that if they did come to market, we would get a call, and we did, and we participated in the process. But it certainly has been one that we've thought of for a long time. There were some capacity constraints in 2018, which I think is one of the reasons why there were some limitations on the revenue growth, if you just look over a three- or four-year time period. All of that has been remedied. with additional investments that DSM has made. So I don't view that DSM has been starving this business for capital, but certainly do view it as an opportunity for us, you know, that it's going to be part of our core business. And I think businesses always flourish and perform better when that's the case. But anyway, I look back over time, and I think DSM has been a good caretaker of the protective materials business. And I think it's opportunistic for us that DSM wants to go in a different direction around health and nutrition, and this is an opportunity for us to go in a direction that's core for us. The latter part of that question may have just been a little bit more around products than end markets. So on the end market side, it really is one of the slides in here that I think helps to illustrate that pretty well with respect to Maybe that's slide 12. And personal protection really is about two-thirds military, one-third law enforcement. The marine and sustainable infrastructure does break down into, I'd say, a handful of subcategories, but largely aligned with the descriptions in there. And then consumer, what you can see here is really these safety gloves, plus you know, the outdoor high-performance applications.

Sorry, apologies. I was asking more from an avian core point of view. Have you seen, like, any signs of a slowdown because of, you know, the war in Europe or rather Russia and Ukraine or China COVID in some of your important core markets in recent weeks, you know, given that your business is such a good indicator of economic activity?

Yep, sorry about that. So, for Asia, I mean, we have definitely been impacted by the lockdowns. And, you know, that started to really impact us in the latter part of the first quarter. And it wasn't just necessarily lockdowns in China, but in general, COVID, specifically the Omicron variant has impacted specific parts of the region. And look, sales were down in Asia for us in the first quarter. I think that's probably the first time that's happened since I've been with the company. So clearly there's been an impact there at this point that really does seem to be COVID driven. We do have orders that are unfilled at this time. And hopefully when they come back online, we can catch up in that regard. You know, look, Europe has got, it's kind of a mixed thing. Transportation is definitely down in Europe. Transportation is down worldwide for us, so we are experiencing that. It's the one that I would point out as probably the most significantly down. It's not a huge market for us, obviously. And then, in general, I would say that, you know, Europe is, of course, just sort of tentative in general right now with respect to the war in Ukraine. What we've put into our model for the full-year EPS does take that into consideration, the biggest impact being that we're not importing anything into Russia or Ukraine any longer at this point. And that's about, let's say, $0.10 or $0.12 on an annualized basis. Thanks a lot. Certainly. That was our last question. Thank you.

At this time, I am showing no further questions. I would like to turn the call back over to Bob Patterson for closing remarks.

Great. Well, thanks, everyone, for your time and attention today. Happy to answer the questions that we were able to. Certainly, if you have more, we'll be able to take care of those offline. We'll be at some conferences here up in the first week in May. where we'll update all of our investor slides with this new information, our outlook statements, and so on. And so look for that information as it comes out. For now, just know we're very excited about the Dyneema acquisition, about our specialty portfolio transformation journey continuing, and we thank you for your support and investment. Take care. Bye for now.

This concludes today's conference call. Thanks for participating. You may now disconnect.